SC seeks Centre response on plea seeking directions to declare cancer 'notifiable disease' nationwide

Written By :  Anshika Mishra
Published On 2025-12-15 12:15 GMT   |   Update On 2025-12-15 12:15 GMT
Advertisement

The Supreme Court on Friday sought responses from the Centre and all State governments on a Public Interest Litigation (PIL) seeking directions to declare cancer a ''notifiable disease'' nationwide, in order to ensure uniform reporting, early detection, and improved patient care.

A Bench comprising Chief Justice Surya Kant and Justices Joymalya Bagchi and Vipul M Pancholi took note of submissions made by advocate Gaurav Kumar Bansal, appearing for the petitioner Dr Anurag Srivastava, a former head of the Department of Surgical Disciplines at AIIMS New Delhi.

Advertisement

For more details, check out the full story on the link below:

Should Cancer be made a notifiable Disease? SC seeks response of Centre


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News